Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04164199
Title Study of Tislelizumab and/or Pamiparib Containing Treatments in Participants With Advanced Malignancies
Recruitment Enrolling by invitation
Gender both
Phase Phase III
Variant Requirements No
Sponsors BeiGene
Indications

Advanced Solid Tumor

Therapies

Pamiparib + Tislelizumab

Pemetrexed Disodium + Tislelizumab

Tislelizumab

Capecitabine + Tislelizumab

Pamiparib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.